What to Expect

Incorrect. Limiting fluid boluses to 10 mL/kg prevents fluid overload and worsening cardiac function in cardiogenic shock.

Incorrect. Atropine is administered at 0.02 mg/kg IV/IO for pediatric bradycardia due to vagal stimulation or primary AV block.

Incorrect. Oxygenation and ventilation are the first-line treatments for bradycardia caused by hypoxia; lidocaine is used for arrhythmias.

Incorrect. Epinephrine is given every 3-5 minutes at 0.01 mg/kg IV/IO to improve perfusion during cardiac arrest.

Incorrect. CPR is initiated to relieve the obstruction and restore ventilation when a child becomes unresponsive.

Incorrect. A 15:2 ratio improves oxygenation and circulation during high-quality infant CPR with two rescuers.

Incorrect. Neonates achieve oxygen saturation of 80-85% within the first 5 minutes as oxygenation gradually improves after birth.

Incorrect. Early administration of epinephrine within 2 minutes improves outcomes in pediatric cardiac arrest.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes to improve perfusion during pediatric cardiac arrest.

Incorrect. Waveform capnography reliably confirms and monitors proper endotracheal tube placement.

Incorrect. Synchronized cardioversion begins at 0.5-1 J/kg for pediatric SVT and may increase to 2 J/kg if needed.

Incorrect. The encircling thumbs technique provides high-quality compressions for infants and ensures uniform pressure distribution.

Incorrect. PEA is a non-shockable rhythm and is treated with high-quality CPR, epinephrine, and addressing reversible causes.

Incorrect. The total fluid bolus dose should not exceed 60 mL/kg to avoid fluid overload during resuscitation in children.

Incorrect. The maximum dose of adenosine for pediatric SVT is 12 mg, administered as a rapid IV push.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore a perfusing rhythm in pediatric cardiac arrest.

Incorrect. During advanced airway CPR, breaths are delivered at 6-8 seconds (10 breaths/min) without pausing chest compressions.

Incorrect. Neonates gradually increase oxygen saturation, starting at 60-65% in the first minute of life, as part of normal postnatal adaptation.

Incorrect. Epinephrine is the drug of choice for treating bradycardia when oxygenation and ventilation do not resolve the issue.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes during pediatric cardiac arrest to improve perfusion.

Incorrect. Epinephrine IM is administered immediately to address airway swelling and improve respiratory function in anaphylaxis.

Incorrect. The total dose of amiodarone during pediatric cardiac arrest should not exceed 15 mg/kg to avoid toxicity.

Incorrect. IV access is the preferred route for drug delivery during resuscitation, ensuring rapid and reliable administration.

Incorrect. Neonates in shock or with hypovolemia should receive a fluid bolus of 10 mL/kg of isotonic crystalloid.

Incorrect. Adenosine is the first-line drug for stable SVT, given as a rapid IV push to interrupt reentrant tachyarrhythmias.

Incorrect. Synchronized cardioversion restores a normal rhythm in unstable SVT to prevent further hemodynamic compromise.

Incorrect. Magnesium sulfate is the treatment of choice for torsades de pointes, stabilizing cardiac cells and correcting QT prolongation.

Incorrect. The target oxygen saturation for neonates in the first minute is 60-65%, gradually increasing to 80-85% by 5 minutes.

Incorrect. Vagal maneuvers are the first-line intervention for stable SVT, promoting parasympathetic activity to terminate the arrhythmia.

Incorrect. CPR is initiated immediately to relieve the obstruction and restore ventilation in an unresponsive child.

Incorrect. Compressions at 1/3 the depth of the chest ensure adequate perfusion without risking internal injuries.

Incorrect. IM epinephrine is the first-line treatment to reduce airway swelling and improve oxygenation.

Incorrect. Adenosine is given as a rapid IV push at 0.1 mg/kg to terminate SVT caused by reentrant pathways.

Incorrect. The maximum dose of adenosine for terminating SVT in pediatric patients is 12 mg, administered as a rapid IV push.

Incorrect. Rescue breaths provide adequate oxygenation and ventilation, preventing cardiac arrest in children with respiratory failure.

Incorrect. Respiratory failure is the leading cause of cardiac arrest in children due to their dependency on oxygenation and ventilation.

Incorrect. Oxygen delivery stabilizes respiratory distress and improves oxygen saturation in pediatric patients.

Incorrect. Synchronized cardioversion restores a stable rhythm in unstable SVT that is refractory to adenosine.

Incorrect. Epinephrine is given every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Rhythm checks are performed every 2 minutes to assess the need for defibrillation or changes in treatment.

Incorrect. High-quality CPR is continued while addressing any potential reversible causes in pediatric PEA.

Incorrect. Waveform capnography reliably confirms ET tube placement and monitors ventilation in real time.

Incorrect. Vagal maneuvers are the first-line intervention for stable SVT to terminate reentrant arrhythmias without drugs.

Incorrect. Maintaining oxygen saturation between 90-95% prevents hypoxia and avoids the risks of hyperoxia in neonates.

Incorrect. Delivering 8-10 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. A compression rate of 100-120 per minute optimizes perfusion while preventing rescuer fatigue.

Incorrect. Amiodarone is the preferred antiarrhythmic for stabilizing wide-complex tachycardia in pediatric patients.

Incorrect. The maximum dose of atropine for pediatric bradycardia is 1 mg for children and 3 mg for adolescents.

Incorrect. Epinephrine is administered at 0.01 mg/kg IV/IO every 3-5 minutes during pediatric cardiac arrest.

Incorrect. Hypoxia is the primary cause of pediatric bradycardia and should be treated with oxygen and ventilation.

Incorrect. Hypovolemia is a reversible cause and is treated with fluid resuscitation to restore circulating volume and perfusion.

Incorrect. Fluids restore perfusion, and antibiotics treat the underlying infection causing septic shock.

Incorrect. Epinephrine is given every 3-5 minutes to enhance coronary and cerebral perfusion during pediatric cardiac arrest.

Incorrect. Vasopressors like epinephrine or dopamine are used to improve cardiac output and perfusion.

Incorrect. Rhythm checks are performed every 2 minutes to assess the need for defibrillation or changes in treatment.

Incorrect. Epinephrine at 0.01 mg/kg IV is administered during neonatal resuscitation to improve cardiac contractility and perfusion.

Incorrect. Defibrillation is the primary intervention for shockable rhythms like VF and pulseless VT in pediatric cardiac arrest.

Incorrect. Neonatal hypovolemic shock is managed with smaller boluses of 10 mL/kg to avoid overloading the circulatory system.

Incorrect. Oxygen saturation should be maintained between 94-98% to prevent hypoxia or hyperoxia during resuscitation.

Incorrect. Maintaining oxygen saturation at 94-98% avoids both hypoxia and the harmful effects of hyperoxia.

Incorrect. During CPR with an advanced airway, 10 breaths per minute ensures adequate oxygenation without causing hyperventilation.

Incorrect. Amiodarone is administered at 5 mg/kg IV/IO during pediatric cardiac arrest for refractory VF or pulseless VT.

Incorrect. A 15:2 ratio is used during pediatric CPR with two rescuers to optimize ventilation and circulation.

Incorrect. Lidocaine is used as an antiarrhythmic in cardiac arrest, with a cumulative dose limit of 3 mg/kg.

Incorrect. A 20 mL/kg bolus of isotonic crystalloid is recommended for children in hypovolemic shock.